Par Drugs and Chemicals Ltd (PARR)

NSE
Currency in INR
193.80
-1.13(-0.58%)
Real-time Data
PARR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
190.00195.00
52 wk Range
180.50348.45
Key Statistics
Edit
Bid/Ask
193.80 / 194.00
Prev. Close
194.93
Open
190
Day's Range
190-195
52 wk Range
180.5-348.45
Volume
3.21K
Average Volume (3m)
254.16K
1-Year Change
-5.72%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PARR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Par Drugs Company Profile

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Employees
122
Market
India

Compare PARR to Peers and Sector

Metrics to compare
PARR
Peers
Sector
Relationship
P/E Ratio
13.1x25.7x−0.6x
PEG Ratio
0.290.280.00
Price/Book
2.5x2.5x2.6x
Price / LTM Sales
2.3x2.5x3.1x
Upside (Analyst Target)
-44.5%54.6%
Fair Value Upside
Unlock−15.5%7.7%Unlock

Earnings

Latest Release
Apr 27, 2023
EPS / Forecast
2.80 / --
Revenue / Forecast
244.90M / --
EPS Revisions
Last 90 days

FAQ

What Is the Par Drugs (PARR) Stock Price Today?

The Par Drugs stock price today is 193.80.

What Stock Exchange Does Par Drugs Trade On?

Par Drugs is listed and trades on the NSE stock exchange.

What Is the Stock Symbol for Par Drugs?

The stock symbol for Par Drugs is "PARR."

What Is the Par Drugs Market Cap?

As of today, Par Drugs market cap is 2.40B.

What is Par Drugs Earnings Per Share?

The Par Drugs EPS is 14.85.

From a Technical Analysis Perspective, Is PARR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.